Resource Library

A single 81 mg aspirin does far more than thin blood. Dr. Seeds explains how acetylation shuts down COX-1 while retasking COX-2 to produce pro-resolving mediators like resolvins and lipoxins from omega-3s, plus its effects on the cGAS-STING pathway, PPAR alpha and the resolution of chronic inflammation, along with who should avoid it.

Red light therapy and cold plunge headline this look at popular rejuvenation tools and where the marketing outruns the science. Dr. Seeds explains how red light sparks the electron transport chain and cytochrome c oxidase to support soft-tissue healing and skin, while cautioning that its effects stay superficial and short-lived.

A back-to-basics look at cellular medicine, told by the innovator behind the framework. Dr. Seeds lays out four pillars: redox balance, mitochondrial signaling, core metabolic pathways, and cellular resilience, then traces how his orthopedic practice revealed that treating the cellular environment, not just the diagnosis, changes patient outcomes.

Sarcopenia takes center stage as Dr. Seeds dismantles the fear that GLP-1 peptides cause muscle loss. Preserving lean mass during weight loss comes down to adequate protein and leucine, resistance training, and slow, deliberate fat loss that lets the body build efficient, mitochondria-rich muscle.

Often overlooked, the lymphatic system drains cellular debris and activates immune defenses through nodes rich in T and B cells. Dr. Seeds explains why lymph flow and the brain's glymphatic drainage are redox-driven, when lymphatic massage genuinely helps, and how stage-four sleep clears amyloid and tau.

Bad breath is often a window into the oral microbiome. Dr. Seeds connects chronic halitosis to dysbiosis, biofilm and plaque, redox imbalance and immune dysregulation in the gums, tracing how these bacteria and their endotoxins contribute to heart disease, neuroinflammation and insulin resistance. Saliva, lactoferrin and flossing emerge as key defenses.

Dr. Seeds answers the podcast's namesake question and defines redox as the movement of electrons in the mitochondria that drives energy production. He walks through reactive oxygen species as signaling agents, the body's own antioxidant system governed by NFR2, and why supplementing antioxidants can disrupt the balance the cell manages on its own.

Platelet-rich plasma delivers a burst of growth factors like PDGF, VEGF, and TGF-beta, but Dr. Seeds argues its roughly fifty-fifty results hinge on the cellular environment it enters. The episode covers preparing patients metabolically, pairing PRP with stem cell signaling, and why insulin resistance is a clear contraindication.

Stem cell clinics promise regeneration, but Dr. Seeds pushes back hard on the marketing. He distinguishes embryonic, mesenchymal, and hematopoietic cells, explains what the FDA actually permits, and stresses that stem cells work through signaling and the secretome, so results depend on first repairing the patient's cellular environment.

Why longevity works better as a marketing term than a health goal. The conversation distinguishes chasing chronological years from building healthspan and biological age, questions whether expensive longevity panels are worth the money, and returns the focus to cellular function as the real target of aging well.